DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/fcafa2/sri_lanka_pharmace) has announced the addition of Business Monitor International's "Sri Lanka Pharmaceuticals and Healthcare Report Q4 2011" report to their extensive offering of pharmaceutical market research publications.
Business Monitor International's (BMI) Sri Lanka Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and regulatory bodies with independent forecasts and competitive intelligence on Sri Lanka's pharmaceuticals and healthcare industry.
The attractiveness of Sri Lanka's pharmaceutical market is underpinned by the well-developed healthcare infrastructure and government initiatives with regard to the improvement of public health indicators. Nevertheless, funding pressures will continue to hamper the development of pharmaceutical values in the country, especially as less than 50% of total healthcare spending is provided by the state.
Headline Expenditure Projections:
- Pharmaceuticals: LKR43.60bn (US$386mn) in 2010 to LKR48.56bn (US$444mn) in 2011; +11.4% in local currency terms and +15.0% in US dollar terms.
- Healthcare: LRK225.42bn (US$2.00bn) in 2010 to LKR252.56bn (US$2.31bn) in 2011; +12.0% in local currency terms and +15.6% in US dollar terms.
- Medical devices: LRK10.10bn (US$90mn) in 2010 to LKR11.09bn (US$101mn) in 2011; +9.8% in local currency terms and +12.0% in US dollar terms.
Key Trends & Developments:
- In August 2011, Health Minister Maithripala Sirisena was reported by Dairy Mirror as saying that patient referrals for private sector laboratory tests by government hospitals are now prohibited.
- In September 2011, Sri Lankan President Mahinda Rajapaksa was seeking to increase the local production of drugs in a bid to lower the number of pharmaceutical items imported from foreign countries, reported Daily News
- In line with the above, an exclusive manufacturing zone for pharmaceutical industry investors is to be established in Kurunegala in the North Western Province of Sri Lanka.
Companies Mentioned:
- State Pharmaceuticals Corporation (SPC)
- Hemas Holdings plc
For more information visit http://www.researchandmarkets.com/research/fcafa2/sri_lanka_pharmace